No Data
Hongyuan Pharmaceutical (301246.SZ): has repurchased a total of 0.53% of its shares.
On January 3, Gelonghui reported that Hongyuan Pharmaceutical (301246.SZ) announced that as of December 31, 2024, the company has repurchased a total of 2,120,200 shares through a dedicated repurchase securities account via centralized bidding, accounting for 0.53% of the company's current total share capital, with a maximum Fill Price of 17.92 yuan/share, a minimum Fill Price of 12.25 yuan/share, and a total transaction amount of 32.792102 million yuan (excluding transaction fees).
Hongyuan Pharmaceuticals (301246.SZ): Sulfide electrolytes can be used in solid state batteries
Gelonghui, November 26th丨 Hongyuan Pharmaceuticals (301246.SZ) stated on the investor interaction platform that sulfide electrolytes can be used in solid state batteries, and the company currently does not have a direct business relationship with contemporary amperex technology.
Hongyuan Pharmaceutical (301246.SZ): has repurchased 0.51% of the shares accumulated.
Gelonghui November 4th | Hongyuan Pharmaceutical (301246.SZ) announced that as of October 31, 2024, the company repurchased a total of 2,020,200 shares of the company through a repurchase dedicated securities account through centralized bidding trading, accounting for 0.51% of the company's current total share capital. The highest fill price was 17.92 yuan per share, the lowest fill price was 12.25 yuan per share, and the total transaction amount was RMB 31.401696 million (excluding trading fees).
Hubei Hongyuan Pharmaceutical Technology's (SZSE:301246) Anemic Earnings Might Be Worse Than You Think
Hongyuan Pharmaceutical: Report for the third quarter of 2024
Hongyuan Pharmaceutical (301246.SZ) released its performance for the first half of the year, with a net income of 36.1422 million yuan, a year-on-year decrease of 62.47%.
Hongyuan Pharmaceutical (301246.SZ) released the third quarter report for 2024, with revenue in the first three quarters reaching 13...
Some Confidence Is Lacking In Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SZSE:301246) As Shares Slide 26%
